These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 19284370)

  • 1. Development of novel drugs targeting inhibitors of apoptosis.
    Flygare JA; Vucic D
    Future Oncol; 2009 Mar; 5(2):141-4. PubMed ID: 19284370
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival and apoptotic signals in the action of microtubule-targeting antitumor drugs.
    Mollinedo F
    IDrugs; 2005 Feb; 8(2):127-43. PubMed ID: 15696415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis: target for novel drugs.
    Alam JJ
    Trends Biotechnol; 2003 Nov; 21(11):479-83. PubMed ID: 14573360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches and therapeutics targeting apoptosis in disease.
    Fischer U; Schulze-Osthoff K
    Pharmacol Rev; 2005 Jun; 57(2):187-215. PubMed ID: 15914467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GADD153 and 12-lipoxygenase mediate fenretinide-induced apoptosis of neuroblastoma.
    Lovat PE; Oliverio S; Ranalli M; Corazzari M; Rodolfo C; Bernassola F; Aughton K; Maccarrone M; Hewson QD; Pearson AD; Melino G; Piacentini M; Redfern CP
    Cancer Res; 2002 Sep; 62(18):5158-67. PubMed ID: 12234979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
    Peart MJ; Tainton KM; Ruefli AA; Dear AE; Sedelies KA; O'Reilly LA; Waterhouse NJ; Trapani JA; Johnstone RW
    Cancer Res; 2003 Aug; 63(15):4460-71. PubMed ID: 12907619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo.
    Vlahakis SR; Bennett SA; Whitehead SN; Badley AD
    Apoptosis; 2007 May; 12(5):969-77. PubMed ID: 17453162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis.
    Bender A; Opel D; Naumann I; Kappler R; Friedman L; von Schweinitz D; Debatin KM; Fulda S
    Oncogene; 2011 Jan; 30(4):494-503. PubMed ID: 20856197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel small molecule inhibitors of caspase-3 block cellular and biochemical features of apoptosis.
    Scott CW; Sobotka-Briner C; Wilkins DE; Jacobs RT; Folmer JJ; Frazee WJ; Bhat RV; Ghanekar SV; Aharony D
    J Pharmacol Exp Ther; 2003 Jan; 304(1):433-40. PubMed ID: 12490620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein synthesis is required for caspase activation and induction of apoptosis by bisphosphonate drugs.
    Coxon FP; Benford HL; Russell RG; Rogers MJ
    Mol Pharmacol; 1998 Oct; 54(4):631-8. PubMed ID: 9765505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited?
    Northington FJ; Graham EM; Martin LJ
    Brain Res Brain Res Rev; 2005 Dec; 50(2):244-57. PubMed ID: 16216332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does resistance to apoptosis affect clinical response to antitumor drugs?
    Borst P; Borst J; Smets LA
    Drug Resist Updat; 2001 Apr; 4(2):129-31. PubMed ID: 11512521
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors.
    Dubrez L; Goldwasser F; Genne P; Pommier Y; Solary E
    Leukemia; 1995 Jun; 9(6):1013-24. PubMed ID: 7596166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Apoptosis: the pharmacological aspects].
    Uteshev DB; Sergeev AV; Uteshev BS
    Eksp Klin Farmakol; 1998; 61(4):57-65. PubMed ID: 9783113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-modulating drugs for improved cancer therapy.
    Ocker M; Höpfner M
    Eur Surg Res; 2012; 48(3):111-20. PubMed ID: 22538523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Proteasome inhibitors: induction of apoptosis as new therapeutic option in prostate cancer].
    Tahmatzopoulos A; Gudegast C; Stöckle M; Wullich B; Unteregger G; Zwergel U; Zwergel T
    Aktuelle Urol; 2004 Nov; 35(6):491-6. PubMed ID: 15526229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An MMP-2/MMP-9 inhibitor, 5a, enhances apoptosis induced by ligands of the TNF receptor superfamily in cancer cells.
    Nyormoi O; Mills L; Bar-Eli M
    Cell Death Differ; 2003 May; 10(5):558-69. PubMed ID: 12728254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle.
    Golsteyn RM
    Cancer Lett; 2005 Jan; 217(2):129-38. PubMed ID: 15617830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targeted pro-apoptotic agents for the treatment of prostate cancer.
    Huang X; Zhang X; Farahvash B; Olumi AF
    J Urol; 2007 Nov; 178(5):1846-54. PubMed ID: 17868738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug discovery targeting apoptosis.
    Huang D; Ichikawa K
    Nat Rev Drug Discov; 2008 Dec; 7(12):1041. PubMed ID: 19065703
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.